Increasing Tysabri Dosing Interval May Cut PML Risk
(MedPage Today) -- No sacrifice of efficacy seen in retrospective analysis.
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news
More News: General Medicine | Tysabri